I see you have been brainwashed into thinking a country with an almost bankrupt health system is going to line Solagran's coffers in exchange for a pine needle extract with no published scientific benefits. Sorry, not going to happen.
There is a reason companies are desperate for FDA approval. Like Bill says, virtually all of the profits are in the North American market.
